{"id":464540,"date":"2023-06-20T19:57:34","date_gmt":"2023-06-21T02:57:34","guid":{"rendered":"https:\/\/nai500.com\/blog\/2023\/06\/%e7%a4%bc%e6%9d%a524%e4%ba%bf%e7%be%8e%e5%85%83%e6%94%b6%e8%b4%ad%e8%bf%99%e5%ae%b6%e7%94%9f%e7%89%a9%e5%88%b6%e8%8d%af%e5%85%ac%e5%8f%b8-%e7%9b%ae%e7%9a%84\/"},"modified":"2023-06-20T19:57:47","modified_gmt":"2023-06-21T02:57:47","slug":"%e7%a6%ae%e4%be%8624%e5%84%84%e7%be%8e%e5%85%83%e6%94%b6%e8%b3%bc%e9%80%99%e5%ae%b6%e7%94%9f%e7%89%a9%e8%a3%bd%e8%97%a5%e5%85%ac%e5%8f%b8-%e7%9b%ae%e7%9a%84","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hant\/blog\/2023\/06\/%e7%a6%ae%e4%be%8624%e5%84%84%e7%be%8e%e5%85%83%e6%94%b6%e8%b3%bc%e9%80%99%e5%ae%b6%e7%94%9f%e7%89%a9%e8%a3%bd%e8%97%a5%e5%85%ac%e5%8f%b8-%e7%9b%ae%e7%9a%84\/","title":{"rendered":"\u79ae\u4f8624\u5104\u7f8e\u5143\u6536\u8cfc\u9019\u5bb6\u751f\u7269\u88fd\u85e5\u516c\u53f8\uff0c\u76ee\u7684\u662f\u4ec0\u9ebc\uff1f"},"content":{"rendered":"<h2>\u901a\u904e\u9019\u7b46\u4ea4\u6613\uff0c\u79ae\u4f86\u5c07\u5169\u6b3e\u5f88\u6709\u524d\u666f\u7684\u81ea\u8eab\u514d\u75ab\u75c5\u85e5\u7269\u6536\u5165\u56ca\u4e2d<\/h2>\n<p>\u4f60\u53ef\u80fd\u6703\u8aaa<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=LLY\">\u79ae\u4f86Eli Lilly and Co\uff08NYSE:LLY\uff09<\/a>\u662f\u5728\u8ced\u535a\u3002\u9031\u4e8c\uff0c\u8a72\u5927\u578b\u88fd\u85e5\u5546\u5ba3\u4f48\u8a08\u5283\u5168\u73fe\u91d1\u6536\u8cfc\u751f\u7269\u88fd\u85e5\u516c\u53f8<a href=\"https:\/\/nai500.com\/zh-hans\/%e8%82%a1%e7%a5%a8%e6%9f%a5%e8%af%a2\/?qm_symbol=DICE\">Dice Therapeutics Inc\uff08NASDAQ:DICE\uff09<\/a>\uff0c\u4ea4\u6613\u50f9\u503c\u7d0424\u5104\u7f8e\u5143\u3002\u79ae\u4f86\u9019\u9ebc\u505a\u7684\u76ee\u7684\u662f\u4ec0\u9ebc\uff1f\u6295\u8cc7\u8005\u9700\u8981\u77ad\u89e3\u4ec0\u9ebc\uff1f<\/p>\n<h2>\u79ae\u4f86\u70ba\u4f55\u8981\u6536\u8cfcDice\uff1f<\/h2>\n<p>\u901a\u904e\u6536\u8cfcDice\uff0c\u79ae\u4f86\u7684\u514d\u75ab\u7814\u767c\u7ba1\u7dda\u5c07\u5f97\u4ee5\u64f4\u5145\u3002Dice\u7684\u4e3b\u8981\u5019\u9078\u7522\u54c1\u662fDC-806\uff0c\u76ee\u524d\u9019\u4e00\u53e3\u670dIL-17\u6291\u5236\u5291\u6cbb\u7642\u4e2d\u5ea6\u81f3\u91cd\u5ea6\u725b\u76ae\u766c\u76842b\u671f\u81e8\u5e8a\u7814\u7a76\u6b63\u5728\u9032\u884c\u4e2d\u3002\u6b64\u5916\uff0c\u53e6\u4e00\u6b3e\u5728\u7814\u85e5\u7269DC-853\u4e5f\u8655\u65bc\u81e8\u5e8a\u968e\u6bb5\uff0c\u4e26\u4e14\u6709\u6548\u6027\u76f8\u8f03DC-806\u9084\u6709\u63d0\u5347\u3002Dice\u9810\u8a08\u4e00\u671f\u7814\u7a76\u7684\u7d50\u679c\u5c07\u57282023\u5e74\u4e0b\u534a\u5e74\u516c\u4f48\u3002<\/p>\n<p>\u9019\u5169\u500b\u7814\u767c\u9805\u76ee\u8ddf\u79ae\u4f86\u76ee\u524d\u7684\u7522\u54c1\u7dda\u548c\u7814\u767c\u7ba1\u7dda\u53ef\u4ee5\u8aaa\u662f\u7d55\u914d\u3002\u5168\u7403\u725b\u76ae\u766c\u5e02\u5834\u7684\u898f\u6a21\u9810\u8a08\u52302030\u5e74\u5c07\u589e\u81f3\u8fd1500\u5104\u7f8e\u5143\u3002\u79ae\u4f86\u76ee\u524d\u6709\u5169\u6b3e\u5df2\u4e0a\u5e02\u7684\u81ea\u8eab\u514d\u75ab\u75be\u75c5\u85e5\u7269\uff0c\u5b83\u5011\u5206\u5225\u70baOlumiant\u548cTaltz\uff0c\u4e26\u4e142023\u5e74\u4e00\u5b63\u5ea6\u7684\u5408\u4f75\u92b7\u552e\u984d\u5c31\u63a5\u8fd18.00\u5104\u7f8e\u5143\u3002\u6b64\u5916\uff0c\u6cbb\u7642\u7570\u4f4d\u6027\u76ae\u819a\u708e\u7684lebrikizumab\u4ee5\u53ca\u6cbb\u7642\u6f70\u760d\u6027\u7d50\u8178\u708e\u7684mirikizumab\u6b63\u5728\u7b49\u5f85\u7f8e\u570b\u98df\u54c1\u85e5\u54c1\u76e3\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u7684\u6279\u51c6\u3002<\/p>\n<h2>\u9019\u500b\u6536\u8cfc\u50f9\u683c\u5408\u7406\u55ce\uff1f<\/h2>\n<p>\u76f8\u6bd4Dice Therapeutics 30\u5929\u7684\u6210\u4ea4\u91cf\u52a0\u6b0a\u5e73\u5747\u4ea4\u6613\u50f9\u683c\uff0c\u79ae\u4f8624\u5104\u7f8e\u5143\u7684\u6536\u8cfc\u50f9\u683c\u6ea2\u50f9\u7387\u572840%\u5de6\u53f3\u3002\u5728\u751f\u7269\u88fd\u85e5\u884c\u696d\uff0c\u9019\u6a23\u7684\u6536\u8cfc\u6ea2\u50f9\u4e26\u4e0d\u7f55\u898b\u3002<\/p>\n<p>Canaccord Genuity\u7684\u5206\u6790\u5e2b\u8a8d\u70ba\uff0cDice\u7684DC-806\u5982\u679c\u7372\u6279\uff0c\u5e74\u5cf0\u503c\u92b7\u552e\u984d\u53ef\u905414\u5104\u7f8e\u5143\u3002\u5982\u679c\u6309\u7167\u9019\u4e00\u9810\u4f30\u6578\u5b57\uff0c\u79ae\u4f86\u7684\u6536\u8cfc\u50f9\u683c\u9084\u7b97\u5408\u7406\u3002\u6b64\u5916\uff0c\u79ae\u4f86\u80a1\u50f9\u7684\u8d70\u52e2\u4e5f\u53cd\u6620\u51fa\u6295\u8cc7\u8005\u7684\u8a8d\u53ef\u614b\u5ea6\u3002\u6536\u8cfc\u6d88\u606f\u516c\u4f48\u5f8c\uff0c\u8a72\u88fd\u85e5\u5de8\u982d\u7684\u80a1\u50f9\u4e0a\u6f32\u8d85\u904e1%\uff0c\u800c\u7576\u5929\u7f8e\u80a1\u4e3b\u8981\u80a1\u6307\u5c0f\u5e45\u4e0b\u8dcc\u3002<\/p>\n<h2>\u76e3\u7ba1\u6a5f\u69cb\u6703\u4e0d\u6703\u5f9e\u4e2d\u963b\u6493\uff1f<\/h2>\n<p>\u7f8e\u570b\u806f\u90a6\u8cbf\u6613\u59d4\u54e1\u6703\uff08FTC\uff09\u6b64\u524d\u66fe\u963b\u6b62\u5b89\u9032Amgen\uff08NASDAQ:AMGN\uff09\u5c0dHorizon Therapeutics\u7684\u6536\u8cfc\uff0c\u76e3\u7ba1\u6a5f\u69cb\u6703\u4e0d\u6703\u4e5f\u6703\u963b\u6493\u79ae\u4f86\u6536\u8cfcDice\uff1f\u9019\u7a2e\u53ef\u80fd\u6027\u5b58\u5728\u4f46\u4e0d\u5927\u3002<\/p>\n<p>\u9019\u5169\u500b\u6536\u8cfc\u7684\u60c5\u6cc1\u5927\u4e0d\u76f8\u540c\u3002\u806f\u90a6\u8cbf\u6613\u59d4\u54e1\u6703\u64d4\u5fc3\u7684\u662f\uff0cHorizon\u7684\u7532\u72c0\u817a\u76f8\u95dc\u773c\u75c5\uff08TED\uff09\u85e5\u7269Tepezza\u4ee5\u53ca\u901a\u98a8\u85e5\u7269Krystexxa\u5728\u5404\u81ea\u7684\u5e02\u5834\u4e0a\u90fd\u4eab\u6709\u58df\u65b7\u5730\u4f4d\uff0c\u5b89\u9032\u6536\u8cfc\u9019\u5169\u6b3e\u85e5\u53ef\u80fd\u6703\u524a\u5f31\u7af6\u722d\u3002\u800c\u79ae\u4f86\u5373\u4f7f\u62ff\u4e0b\u4e86Dice\u7684\u7814\u767c\u9805\u76ee\uff0c\u5c0d\u514d\u75ab\u5e02\u5834\u7684\u7af6\u722d\u4e26\u4e0d\u6703\u5e36\u4f86\u91cd\u5927\u7684\u5f71\u97ff\u3002<\/p>\n<h2>\u4ea4\u6613\u9810\u8a08\u4f55\u6642\u5b8c\u6210\uff1f<\/h2>\n<p>\u9019\u8d77\u6536\u8cfc\u5fc5\u9808\u7372\u5f97\u53cd\u58df\u65b7\u6a5f\u69cb\u7684\u6279\u51c6\u3002\u6b64\u5916\uff0c\u79ae\u4f86\u9084\u8a08\u5283\u8981\u7d04\u6536\u8cfcDice\u7684\u7d55\u5927\u591a\u6578\u767c\u884c\u5728\u5916\u80a1\u7968\u3002\u5982\u679c\u8981\u7d04\u6536\u8cfc\u6210\u529f\u5b8c\u6210\uff0c\u516c\u53f8\u5c07\u4ee5\u540c\u6a23\u7684\u8981\u7d04\u50f9\u683c\u901a\u904e\u7b2c\u4e8c\u6b65\u5408\u4f75\u6536\u8cfc\u5269\u9918\u7684\u80a1\u4efd\u3002\u5169\u5bb6\u516c\u53f8\u7684\u8463\u4e8b\u6703\u5df2\u7d93\u6279\u51c6\u4e86\u9019\u4e00\u4ea4\u6613\uff0c\u4e26\u4e14\u79ae\u4f86\u6c92\u6709\u65b0\u7684\u6536\u8cfc\u878d\u8cc7\u63aa\u65bd\uff08\u622a\u81f33\u670831\u65e5\uff0c\u8a72\u516c\u53f8\u6301\u6709200\u5104\u7f8e\u5143\u7684\u6d41\u52d5\u8cc7\u7522\uff09\u3002\u5982\u679c\u76e3\u7ba1\u5c64\u9762\u548c\u8981\u7d04\u6536\u8cfc\u90fd\u9806\u5229\u63a8\u9032\uff0c\u79ae\u4f86\u9810\u8a08\u4ea4\u6613\u5c07\u57282023\u5e74\u4e09\u5b63\u5ea6\u5b8c\u6210\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u901a\u904e\u9019\u7b46\u4ea4\u6613\uff0c\u79ae\u4f86\u5c07\u5169\u6b3e\u5f88\u6709\u524d\u666f\u7684\u81ea\u8eab\u514d\u75ab\u75c5\u85e5\u7269\u6536\u5165\u56ca\u4e2d \u4f60\u53ef\u80fd\u6703\u8aaa\u79ae\u4f86Eli Lilly and Co\uff08NY [&hellip;]<\/p>\n","protected":false},"author":27,"featured_media":456063,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1522,431],"tags":[793,927,563,564],"class_list":["post-464540","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1522","category-trends-strategies-zh-hant","tag-793","tag-927","tag--zh-hant","tag-564","sectors-life-science-zh-hant","locations-us-zh-hant","exchange-nasdaq-zh-hant","exchange-nyse-zh-hant"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/464540","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/comments?post=464540"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/posts\/464540\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media\/456063"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/media?parent=464540"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/categories?post=464540"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hant\/wp-json\/wp\/v2\/tags?post=464540"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}